These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 32946005)

  • 1. Solid state NMR assignments of a human λ-III immunoglobulin light chain amyloid fibril.
    Pradhan T; Annamalai K; Sarkar R; Hegenbart U; Schönland S; Fändrich M; Reif B
    Biomol NMR Assign; 2021 Apr; 15(1):9-16. PubMed ID: 32946005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seeded fibrils of the germline variant of human λ-III immunoglobulin light chain FOR005 have a similar core as patient fibrils with reduced stability.
    Pradhan T; Annamalai K; Sarkar R; Huhn S; Hegenbart U; Schönland S; Fändrich M; Reif B
    J Biol Chem; 2020 Dec; 295(52):18474-18484. PubMed ID: 33093170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid-state NMR chemical shift assignments for AL-09 V
    Piehl DW; Blancas-Mejía LM; Ramirez-Alvarado M; Rienstra CM
    Biomol NMR Assign; 2017 Apr; 11(1):45-50. PubMed ID: 27771830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanistic insights into the aggregation pathway of the patient-derived immunoglobulin light chain variable domain protein FOR005.
    Pradhan T; Sarkar R; Meighen-Berger KM; Feige MJ; Zacharias M; Reif B
    Nat Commun; 2023 Jun; 14(1):3755. PubMed ID: 37353525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fatal amyloid formation in a patient's antibody light chain is caused by a single point mutation.
    Kazman P; Vielberg MT; Pulido Cendales MD; Hunziger L; Weber B; Hegenbart U; Zacharias M; Köhler R; Schönland S; Groll M; Buchner J
    Elife; 2020 Mar; 9():. PubMed ID: 32151314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of two principal amyloid-driving segments in variable domains of Ig light chains in systemic light-chain amyloidosis.
    Brumshtein B; Esswein SR; Sawaya MR; Rosenberg G; Ly AT; Landau M; Eisenberg DS
    J Biol Chem; 2018 Dec; 293(51):19659-19671. PubMed ID: 30355736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (1)H, (15)N and (13)C resonance assignments for 3rC and 3rCWP: amyloidogenic variants of imunoglobulin λ 3 light-chain.
    Gil-Rodríguez P; Amero C
    Biomol NMR Assign; 2015 Apr; 9(1):139-42. PubMed ID: 24816896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mass spectrometry characterization of light chain fragmentation sites in cardiac AL amyloidosis: insights into the timing of proteolysis.
    Lavatelli F; Mazzini G; Ricagno S; Iavarone F; Rognoni P; Milani P; Nuvolone M; Swuec P; Caminito S; Tasaki M; Chaves-Sanjuan A; Urbani A; Merlini G; Palladini G
    J Biol Chem; 2020 Dec; 295(49):16572-16584. PubMed ID: 32952127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cryo-EM structure of a light chain-derived amyloid fibril from a patient with systemic AL amyloidosis.
    Radamaker L; Lin YH; Annamalai K; Huhn S; Hegenbart U; Schönland SO; Fritz G; Schmidt M; Fändrich M
    Nat Commun; 2019 Mar; 10(1):1103. PubMed ID: 30894526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tyrosine residues mediate fibril formation in a dynamic light chain dimer interface.
    DiCostanzo AC; Thompson JR; Peterson FC; Volkman BF; Ramirez-Alvarado M
    J Biol Chem; 2012 Aug; 287(33):27997-8006. PubMed ID: 22740699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates.
    Khurana R; Gillespie JR; Talapatra A; Minert LJ; Ionescu-Zanetti C; Millett I; Fink AL
    Biochemistry; 2001 Mar; 40(12):3525-35. PubMed ID: 11297418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Substantial Structural Conversion of the Native Monomer Leads to in-Register Parallel Amyloid Fibril Formation in Light-Chain Amyloidosis.
    Lecoq L; Wiegand T; Rodriguez-Alvarez FJ; Cadalbert R; Herrera GA; Del Pozo-Yauner L; Meier BH; Böckmann A
    Chembiochem; 2019 Apr; 20(8):1027-1031. PubMed ID: 30565364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryo-EM reveals structural breaks in a patient-derived amyloid fibril from systemic AL amyloidosis.
    Radamaker L; Baur J; Huhn S; Haupt C; Hegenbart U; Schönland S; Bansal A; Schmidt M; Fändrich M
    Nat Commun; 2021 Feb; 12(1):875. PubMed ID: 33558536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light chain mutations contribute to defining the fibril morphology in systemic AL amyloidosis.
    Karimi-Farsijani S; Pfeiffer PB; Banerjee S; Baur J; Kuhn L; Kupfer N; Hegenbart U; Schönland SO; Wiese S; Haupt C; Schmidt M; Fändrich M
    Nat Commun; 2024 Jun; 15(1):5121. PubMed ID: 38879609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanism of amyloidogenic mutations in hypervariable regions of antibody light chains.
    Rottenaicher GJ; Weber B; Rührnößl F; Kazman P; Absmeier RM; Hitzenberger M; Zacharias M; Buchner J
    J Biol Chem; 2021; 296():100334. PubMed ID: 33508322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MAK33 antibody light chain amyloid fibrils are similar to oligomeric precursors.
    Hora M; Sarkar R; Morris V; Xue K; Prade E; Harding E; Buchner J; Reif B
    PLoS One; 2017; 12(7):e0181799. PubMed ID: 28746363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cryo-EM structure of cardiac amyloid fibrils from an immunoglobulin light chain AL amyloidosis patient.
    Swuec P; Lavatelli F; Tasaki M; Paissoni C; Rognoni P; Maritan M; Brambilla F; Milani P; Mauri P; Camilloni C; Palladini G; Merlini G; Ricagno S; Bolognesi M
    Nat Commun; 2019 Mar; 10(1):1269. PubMed ID: 30894521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in specific structural regions of immunoglobulin light chains are associated with free light chain levels in patients with AL amyloidosis.
    Poshusta TL; Sikkink LA; Leung N; Clark RJ; Dispenzieri A; Ramirez-Alvarado M
    PLoS One; 2009; 4(4):e5169. PubMed ID: 19365555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruitment of Light Chains by Homologous and Heterologous Fibrils Shows Distinctive Kinetic and Conformational Specificity.
    Blancas-Mejía LM; Ramirez-Alvarado M
    Biochemistry; 2016 May; 55(21):2967-78. PubMed ID: 27158939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations can cause light chains to be too stable or too unstable to form amyloid fibrils.
    Marin-Argany M; Güell-Bosch J; Blancas-Mejía LM; Villegas S; Ramirez-Alvarado M
    Protein Sci; 2015 Nov; 24(11):1829-40. PubMed ID: 26300552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.